Drugs / Adjuvanted QIV
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02583256 | Jan → Nov 2016 | influenza | Seqirus | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Adjuvanted QIV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02583256 ↗ |
| Known as | aQIV | “Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV)” NCT02583256 ↗ |
| Modality | Vaccine | “Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV)” NCT02583256 ↗ |